12:54 PM
 | 
Apr 27, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Nextech leads Revolution Medicines' $56M series B

Revolution Medicines Inc. (Redwood City, Calif.) raised $56 million in a series B round led by new investor Nextech Invest, with participation by new investors Casdin Capital and Schroder Adveq and existing investors The Column Group and Third Rock Ventures.

This year, the company plans to start a clinical trial of...

Read the full 236 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >